Mark Bachleda serves as Executive at Galera Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mark Bachleda has executed 1 insider transactions totaling $24.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 16, 2023 involved purchasing 11,000 shares valued at $24.8K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 16, 2023 | GRTX | $24.8K | Purchase | 11,000 | $2.25 | Discretionary |
Mark Bachleda currently holds 11,000 shares of Galera Therapeutics, Inc. (GRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Bachleda has been a net buyer of GRTX stock. They have purchased $24.8K and sold $0 worth of shares.
Mark Bachleda's most recent insider trade was on Mar 16, 2023, when they purchased 11,000 shares at $2.25 per share.
Get notified when new Form 4 filings are submitted